Outcomes measures included length of stay (in ED and hospital), and mortality (in ED and hospital, and 1 month, and three after discharge).
Proxy cost measures included length of stay, readmission rates, resource utilization metrics (e.g., imaging studies), adverse events, and process measures correlated with adverse events.
The main outcome measures included length of gestation, prolonged pregnancy and delivery outcomes such as need for caesarean section following IOL.
Other important outcome measures include length of stay, hospital acquired infections, venous thromboembolism, readmission rates, cause-specific mortality, and in-hospital mortality.
Secondary outcome measures include length of stay at diagnosis, growth, adverse events, quality of life, anxiety, coping with diabetes, diabetes knowledge, home/clinic visits, self-care activity, satisfaction and time off school/work.
The phenotypic characteristics measured included length, mass, condition factor (mass · length−3), survival, colour, fin quality, disease presence, gill Na+/K+−ATPase activity level, microarray gene expression profile, predator avoidance ability, swimming endurance and migratory behaviour including speed, timing and habitat use.
Ward functioning was inferred from standard measures of care including length of stay, complaints, and adverse events.
Opioid tolerant patients were then compared to the control for outcomes measures including observed length of stay and readmission rates.
Skin and soft tissue infections There are no published reports regarding the impact that POCUS has on emergency department outcome measures (including morbidity, length of stay, cosmetic results, and cost effectiveness).
Voids in the literature Skin and soft tissue infections There are no published reports regarding the impact that POCUS has on emergency department outcome measures (including morbidity, length of stay, cosmetic results, and cost effectiveness).
